Interpreting Oral SERD Trial Data to Guide Metastatic Breast Cancer Care
Project Oncology®Interpreting Oral SERD Trial Data to Guide Metastatic Breast Cancer Care
Alexandria May, PharmD, BCPS
Neil M. Iyengar, MD
First-Line ADCs in Metastatic Triple-Negative Breast Cancer
On the Frontlines of Metastatic Breast CancerFirst-Line ADCs in Metastatic Triple-Negative Breast Cancer
Alexandria May, PharmD, BCPS
Heather McArthur, MD, MPH, FASCO
Zidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
On the Frontlines of Non-Small Cell Lung CancerZidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
Ryan Quigley
Alexander Drilon, MD
From Evidence to Practice: Advances in Malignant Pleural Effusion Management
Clinician's RoundtableFrom Evidence to Practice: Advances in Malignant Pleural Effusion Management
Nicholas Pastis, MD
Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Project Oncology®Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Steve Jackson, PharmD
Paolo F. Caimi, MD
Narendranath Epperla, MD, MS
Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Clinician's RoundtablePersonalized CRC Screening: Applying Real-World Evidence to Test Selection
Brian P. McDonough, MD, FAAFP
David A. Johnson, MD, FACG, FACP
- advertisement
- 4 questions
- 3 questions
- 4 questions
- 2 questions
- 10 questions
- 4 questions
- advertisement
What Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Medical Industry FeatureWhat Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Jennifer Caudle, DO, FACOFP
Syma Iqbal, MD
Cerebral Organoid Model Transforms Glioblastoma Research
Medical Industry FeatureCerebral Organoid Model Transforms Glioblastoma Research
Howard Fine, M.D.
Advancing Care in Chronic GVHD: Evolving Therapeutic Insights
Project Oncology®Advancing Care in Chronic GVHD: Evolving Therapeutic Insights
Brian P. McDonough, MD, FAAFP
Brooke Adams, PharmD, BCOP
BRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Medical Industry FeatureBRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Sharyn N. Lewin, MD, FACS, FACOG
Dana Chase, MD
ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Medical Industry FeatureReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Sarah Sammons, MD
Identifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Medical Industry FeatureIdentifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Sandhya Panch, MD, MPH
- 10/29/2026
- 10/28/2026
- 10/28/2026
- 10/23/2026
- 10/23/2026
- 10/22/2026